What is Hayat Pharmaceutical Industries Co Net Margin %?
Hayat Pharmaceutical Industries CoAMM:HPIC 79 Net Margin % is 7.57% as of Mar. 2026, which is 64% below its 10-year median of 20.91. GuruFocus rates AMM:HPIC with a GF Score™ of 79/100 and a GF Value™ of JOD2.74 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 956 Drug Manufacturers companies, Hayat Pharmaceutical Industries Co ranks better than 70.4% on this metric.
AMM:HPIC'
s Net Margin % Range Over the Past 10 Years
Min: 11.94 Med: 20.91 Max: 22.3
Current: 11.94
AMM:HPIC's Net Margin % is ranked better than 70.4% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs AMM:HPIC: 11.94
Hayat Pharmaceutical Industries Co (AMM:HPIC) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Hayat Pharmaceutical Industries Co Net Margin % Related Terms
Hayat Pharmaceutical Industries Co Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co Net Margin % Chart
AMM:HPIC vs ZTS, UTHR, VTRS: Net Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hayat Pharmaceutical Industries Co Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Hayat Pharmaceutical Industries Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Net Margin % of 7.57% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Hayat Pharmaceutical Industries Co and its competitors. This is 64% below median its historical median of 20.91. Over the past decade, Hayat Pharmaceutical Industries Co's Net Margin % has ranged from 11.94 to 22.30. According to the industry distribution chart, Hayat Pharmaceutical Industries Co ranks #283 out of 956 companies in the Drug Manufacturers industry, placing it in the top 29.6%.
Is Hayat Pharmaceutical Industries Co's Net Margin % too high?
Hayat Pharmaceutical Industries Co's current Net Margin % of 7.57% is 64% below median its 10-year median of 20.91. Over the past 10 years, this metric has ranged from a low of 11.94 to a high of 22.30. The Drug Manufacturers industry median Net Margin % is 5.56. Hayat Pharmaceutical Industries Co's value of 7.57% is 36.2% above this industry median. Based on the distribution chart, Hayat Pharmaceutical Industries Co ranks #283 out of 956 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hayat Pharmaceutical Industries Co ranks #283 out of 956 companies for Net Margin %. This puts Hayat Pharmaceutical Industries Co in the upper half of its industry. The industry median Net Margin % is 5.56. Hayat Pharmaceutical Industries Co's value of 7.57% is 36.2% above this benchmark. Historically, Hayat Pharmaceutical Industries Co's own Net Margin % has ranged from 11.94 to 22.30 over the past decade. While the company's 10-year median is 20.91 vs. the industry median of 5.56, Hayat Pharmaceutical Industries Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hayat Pharmaceutical Industries Co's current Net Margin % of 7.57% is 36.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Hayat Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hayat Pharmaceutical Industries Co's current Net Margin % is 7.57%, which is 64% below median its own 10-year median of 20.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co (AMM:HPIC) is currently considered Modestly Overvalued. The stock's GF Value™ is JOD2.74, compared to a current price of JOD3.12 — trading 13.9% above its estimated fair value. The current Net Margin % is 7.57%, which is 64% below median its 10-year median of 20.91 and 36.2% above the Drug Manufacturers industry median of 5.56. Hayat Pharmaceutical Industries Co's overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Net Margin % is 7.57% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hayat Pharmaceutical Industries Co (AMM:HPIC) Overvalued in 2026?
Based on GuruFocus' analysis, Hayat Pharmaceutical Industries Co stock appears to be overvalued.
The current stock price of JOD3.12 is trading 13.9% above its estimated GF Value™ of JOD2.74.
GuruFocus considers Hayat Pharmaceutical Industries Co to be Modestly Overvalued.
Key valuation signals for AMM:HPIC:
Net Margin %: 7.57% (64% below median its 10-year median of 20.91)
GF Value™: JOD2.74 vs. price of JOD3.12 (13.9% above fair value)
Industry Position: 36.2% above the Drug Manufacturers median (#283 of 956)
No single metric tells the full story. See the AMM:HPIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hayat Pharmaceutical Industries Co Business Description
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
79GF Score
Get the complete analysis for AMM:HPIC
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:HPIC has been successfully added to your 
